chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feeling achy in shoulders back and legs.; feeling achy in shoulders back and legs.; feeling achy in shoulders back and legs.; This is a spontaneous report from a contactable consumer(patient). A 72-years-old male patient received bnt162b2 (BNT162B2, solution for injection, Batch/Lot number was not reported) second dose via an unspecified route of administration on an unspecified date as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. Reported that he has had the second dose 2 weeks ago and is feeling achy in shoulders back and legs. Outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Bad body aches from lower back down legs; Unwell feeling all night; feverish; chills; bad taste in mouth; restless; Stomach turning; A red very warm blotch on my arm around the injection site; Anxiety; Feelings disappeared then came back not as harsh around 30 hours after; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 44-years-old non-pregnant female patient received bnt162b2 (BNT162B2, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot Number: EN8581) as unknown, single for covid-19 immunisation. Medical history included CVC (Central venous catheter). Concomitant medications included Metoprolol succinate 25 mg, Omeprazole 40 mg, Cetirizine hydrochloride. Patient had known allergies. Patient did not receive any other vaccine within 4 weeks. Patient neither diagnosed with COVID-19 prior to vaccination nor been tested for COVID-19 post vaccination. On an unknown date, the patient experienced bad body aches from lower back down legs 12 hours later, unwell feeling all night, feverish, chills and bad taste in mouth, restless, stomach turning. Her feelings disappeared then came back not as harsh around 30 hours after. Patient went to work feeling ok thought she was back to normal but when she showered, she noticed a red very warm blotch on her arm around the injection site which slightly disappeared after 12 hours and had anxiety. The patient was recovering from the event red very warm blotch on her arm around the injection site. The outcome of all other events was reported as unknown.  No follow-up attempts are possible. No further information is expected.
Vaccine given was administered on 12/16/22 and expired 12/15/22. Patient did not report any side effects and declined additional dose after speaking with provider.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021 at 11:19 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 11-Jan-2021 at 11:19 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 50.61.  No concomitant medications were reported.  Batch number 041L20A administered on 11-Jan-2021 had  temperature 35 from 02:00 PM to 10:00 AM. This vial was moved to fridge on 08-Jan-2021 and beyond use date for the vial was reported as 07-Feb-2021. Product moved to clinic on 11-Jan-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.  No treatment medications were reported    This case was linked to US-irms-MOD22-014007 (E2B Linked Report).; Sender's Comments:  US-irms-MOD22-014007:
Fever Chills Muscle Aches Fatigue Pain, redness and swelling at injection site
Erythema, swelling & warmth around site. Generalized pruritus without rash.
pt recvd vax;started coughing & could not catch breath;asthma inhaler did not help;to MD;given epi & breathing meds;pt fine but not sure if she would have breathing diff again;
Swollen, tender, red, hot area at injection site.  Keflex started 500mg RO BID x 7 days.  Follow up on Monday-to urgent care of worse.
pt devel rash on face (face like a rash around eyes across nose & above upper lip) on elbows;denies rash on trunk or lower extremities;
About 7:30 pm, patient's Mother noticed some "hives" on child's ankles, neck, and legs. He seemed very tired and took a short nap. He was given an oral antihistamine at 8:30 pm. Mom reported that he ate a good supper and acted fine, slept well that night. Hives were gone the next morning (10/12/18) but the child complained of his leg hurting and seemed very tired, not interested in playing with siblings and friends. He was given TYLENOL and then took a long nap. After he woke up, he was acting fine, no further hives.
Information has been received concerning a 5 year old female who on 08/13/1999 was vaccinated with a first dose of varicella virus vaccine live in the right arm.  Concomitant therapy that day included a first dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live, in the right arm.  There was no illness at the time of vaccination.  On 05/21/2004 at 13:30 the patient experienced varicella.  Subsequently, the patient recovered from varicella.  It was noted that the patient's father had shingles 2 weeks ago.  On 05/21/2004 the patient presented at an office visit with rash noted at 13:30 and increased spots by 16:00 - scalp, face, trunk, extremities less than 50 lesions.  The patient was diagnosed with varicella.  Subsequently the patient recovered.  Additional information has been requested.
pt recv vax;c/o redness & lump at inject site 12 hrs p/ vax;1 wk post vax,small red streak(approx 30mm);cleared 2 wk post vax
8 hours after the injection I got a terrible headache. Then severe chills that were at the core of my insides. They were so painful. Then body aches and a sore arm.  This lasted until today 1/7/2021.  I still have a slite headache. I took Tylenol and Advil.  Nothing helped.
04/20/2021 woke up with fever, body aches and chills.  04/22/2021 Began to notice drooping on left eyebrow and eye.  04/28/2021 Advised by PCP office to seek medical attn at Urgent Care. That Urgent Care Physician advised me to go to the ER.  04/28/2021 ER Physician determined I needed to be admitted. I was there for 1 night after it was determined by Neurologist I was experiencing Bells Palsy from Moderna Vaccine.
Chills, gone after 12 hours;  Tiredness, gone after 21 hours, Racing mind, gone after 21 hours; Sore deltoid, gone after 3 days; Redness/Itching/slight inflammation at injection site gradually reducing and gone after 6 days
pt recv vax 25SEP96 & 28SEP noted a lump about the size of a twenty five cent piece only oval not round;not red or hot;but painful to touch;had a sl fever;evening p/vax;3OCT taken to MD;MD felt this lump was a rxn to vax;lump getting
MISSED THE DAY TO TAKE SECOND DOSE; This spontaneous case (PVX2019-1415) was received from a consumer on 01-Jun-2019. It describes a female consumer who "missed the day to take second dose", while being on Vivotif for an unknown indication.  Case report: The consumer was taking Vivotif, missed to take second dose on scheduled time (Friday) and took it on Saturday.  Action taken with Vivotif was not applicable.  The clinical outcome of the event "missed the day to take second dose" was unknown.  Company's Comment: The causality of the event "missed the day to take second dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed the day to take second dose" was considered as not applicable.
Immediate pain in vaccinated arm with numbness and tingling to same hand and fingers. Extreme limitation with range of motion.
For the first 24 hours there was mild to moderate pain radiating from the injection site. After about 3-4 hours there was also a headache that slowly grew in intensity until I had to run to the gas station for aspirin (poor planning on my part.) Before the aspirin started to work I would put the headache at a 7, on a pain scale of 1-10. After five aspirin and a good night's sleep, the headache was gone completely and the arm pain was almost completely gone, except for the injection site itself which feels like it's just mildly bruised.  However there is a mild but persistent dizziness that I am still experiencing, approximately 30 hours after the injection. I think this mild dizziness was the first noticeable symptom that I felt after receiving the dose. It is mild enough that I can stand and walk around without any problems, but I'm unsure as to how safe I would be driving in this condition. I am reporting this because I looked at the list of common side effects for Pfizer, and after browsing Google for a while I saw no list that contained "dizziness" or inner-ear imbalance as a symptom. Now, it may be that I'm only experiencing a very mild form of what other people report as "chills" or "nausea", but I don't feel cold or sick to my stomach at all. I just ate a sizeable meal and still feel fine, just a little dizzy. If I stand and turn around or move my head too quickly, I get a little disoriented for a moment. Dizziness is not a normal thing for me, much less normal than the headache I experienced. This is not debilitating and I'm not particularly concerned but I felt that it should at least be made note of somewhere.
Fever; Mild headache; Fatigue; This is a spontaneous report from the Pfizer-Sponsored program received by a contactable consumer.  A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EH9899 with Expiration Date Mar2021), via intramuscular, on 17Dec2020 at single dose for COVID-19 immunisation. The patient did not have a relevant medical history and concomitant medications.. On 19Dec2020, the patient developed mild headache and fatigue.  On 20Dec2020, the patient experienced fever. She stated ''I will take some paracetamol (TYLENOL) whatever for next couple days, if it is not then I need to get COVID Test''. The outcome of the events was unknown.
Nausea and muscle pain. Very uncomfortable leading to fever , hot and cold sweats and very tired. Lasted 2 days
Pt presented to facility after recieving the Pneumovax Vaccine at the medical clinic, prescribed by Dr. with pain, redness, swelling at injection site.  Dr. prescribed Clarinex 5mg, ice/heat and ibuprofen for pain.
Acute liver failure without hepatic coma. Nephrology consulted and recommended octreotide, midodrine, and albumin which she received for 9 days. Renal functions progressively worsened despite triple therapy, and she started dialysis on 11/17. Hospital admission was within 6 weeks of receiving the COVID vaccine.
No additional AE or PQC reported.; Caller explained VARIVAX was delivered on 07JUN2022 after the receive by date of 06JUN2022 and was administered to a patient.; This spontaneous report was received from a medical technologist lab manager referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not reported.  On 07-JUN-2022, varicella virus vaccine live (oka/merck) (VARIVAX), formulation was defaulted to subcutaneous injection, lot number: W002599, expiration date: 24-JAN-2024 was delivered after the receive by date of 06-JUN-2022. On 15-JUN-2022, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (dose, dose number, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No additional adverse event (AE) or product quality complaint (PQC) was reported (no adverse event). There was no reported previous temperature excursion.
Rec'd MMR/TD on same day - became achy, w/t100.8 next day;
Pt seen 24 hrs later with c/o itching pain and erythema at site. On PE had 4x5cm area of erythema, tenderness, pruritus, no wheezing.
On 10/26/2010 she had a high fever. Then on 10/27/2010 she started choking. That night she vomited ALL over the place 3 times 4 min apart. She choked each time. Really choked to the point breathing was difficult and almost impossible. She now wheezes and has trouble breathing here and there.
Pain radiating from point of injection up toward neck and down through the arm, severely restricting movement for over two months.  Though my arm is still sore today, movement is much better and pain has decreased.
the vaccine splashed in MD eye;MD flushed eyes w/water;hr later was feeling a bit sore from the water;
Lethargy; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy) and FATIGUE (Tiredness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LETHARGY (Lethargy) and FATIGUE (Tiredness). At the time of the report, LETHARGY (Lethargy) and FATIGUE (Tiredness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-321164 (Patient Link).
Persistent pain in both legs the day after the vaccination. Legs felt heavy and painful for approximately 24 hours. It started the morning after the vaccination.
Narrative: COVID infection following COVID vaccine series 03/23, Pfizer, dose #1 04/13, Pfizer, dose #2 12/25 COVID swab, result: detected 12/22 pt cc: cough, exposure: unknown 12/25 pt admit ED cc: cough dx: covid 19 infection LOS: I day 12/25 CXR impression: Lungs: Mild left retrocardiac opacity which may represent atelectasis versus early consolidation.. Cardiomediastinal silhouette: No enlargement of the cardiomediastinal silhouette. Bones and soft tissues: No acute finding. 12/29 clinically resolved
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 34 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 17Nov2021 (Lot number: EW0196) at the age of 34 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Lot Number: EL3247), administration date: 03Mar2021, when the patient was 33 years old, for COVID-19 immunisation; Bnt162b2 (Dose Number: 2, Lot Number: EL3247), administration date: 24Mar2021, when the patient was 33 years old, for COVID-19 immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 17Nov2021, outcome "unknown", described as "booster"; PAIN (non-serious), outcome "unknown", described as "Body aches"; ABDOMINAL PAIN UPPER (non-serious), outcome "unknown", described as "stomach pain"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm"; AXILLARY PAIN (non-serious), outcome "unknown", described as "sore underarm"; HEADACHE (non-serious), outcome "unknown", described as "headache"; CHILLS (non-serious), outcome "unknown", described as "chills". No follow-up attempts are possible. No further information is expected.
vomiting several (3-4) times per day in the AM w/diarrhea every other day, starting the day p/shot & cont thru 21NOV;afeb throughout; tolerated liquids throughout
This spontaneous report was received from a physician and a Medical Assistance referring to a patient of unknown age and unknown gender. The patient's concurrent conditions and medical history were not reported. On an unknown date the patient was vaccinated with a dose of GARDASIL (Lot No L040459; Expiration date 06-APR-2017) (dose, and route was not provided). Concomitant therapies included M-M-R II (Lot No: L24268; expiration date: 01-JUL-2017). The physician reported that the patient received improperly stored GARDASIL. The vaccine was improperly stored for a time frame of 17.5 hours. There was not previous temperature excursion. No adverse effects were reported. The M-M-R II remained in recommended storage range. This is one of several reports from the same source. Additional information has been requested.
Within 24 hours post vax, the pt developed mild erythema that progressed. Site was red, pruritic, and warm. He complained of difficulty swallowing. No sore throat, dysphagia, or dyspnea. Referred to allergist.
Information has been received from a pharmacist referring to a 77 years old male patient. The patient's medical histories included congestive heart failure and cellulitis. The patient had no known drug allergies. Concomitant therapy was not reported. On 23-AUG-2016, the patient was vaccinated with a dose of ZOSTAVAX 19400 PFU (once, dose, lot # and expiration date not reported) subcutaneously in the left deltoid. On an unknown date in 2016, the patient experienced redness and swelling at the injection site. The patient went to an unspecified walk in clinic, where he did not have a fever, and was told he had cellulitis at left deltoid. It was unknown if any treatment was provided by the walk in clinic to the patient. The outcome of the event was unknown. The causality between ZOSTAVAX and the event was not provided. Additional information has been requested.
This is spontaneous report from a Pfizer sponsored program from a contactable consumer reporting for herself. A female patient of an unspecified age and ethnicity received PREVNAR 13 at single dose on an unknown date for pneumonia. The patient medical history and concomitant medications were not reported. The patient previously took PREVNAR 13 for immunisation. Patient had a 2nd PREVNAR 13 dose approximately 3 years before this report. Then she developed great deal of pain in her left arm and limited movement. She stated it got very painful and the she believed it was from the PREVNAR 13. She had a free dose of PREVNAR 13, 8 years before this report. She then went back to her HCP (she thought about 3 years before this report) and they said she could have another dose. She said the nursing staff were saying she did not get a shot 3 years before this report. She stated that the pain was so bad, on a scale of 1-10 it is sometimes a 10. The outcome of the events was unknown. All the dates were unknown as the caller had no record. She was not sure of the start date for her symptoms.
After the vaccine, I walked around the store for 1 hour, went home, everything was fine until the next morning when I woke up with a headache, I took Advil, 4 hours after I took Tylenol, 4 hours later I took 2 more Advil. I took my pressure, and it was 190/80. I went to lay down and my stomach starting to get bad. That day, I had an appointment to take my friend to see a doctor and I asked the nurse there about my blood pressure and it was 184/94, she recommended for me to see a doctor (but I didn't). Two days later I still have the headache and it lasted for two weeks. I saw my doctor yesterday, and he said to keep taking Tylenol and Advil.
G51.0 RIGHT FACIAL PALSY 3/27/2023 (blank)
1st dose of Moderna Covid vaccine to be administered to a 17 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st dose of Moderna Covid vaccine to be administered to a 17 year old) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st dose of Moderna Covid vaccine to be administered to a 17 year old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st dose of Moderna Covid vaccine to be administered to a 17 year old) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No treatment medications were reported.
Starting at midnight 2 days after vaccines he developed progressive vomiting which became bilious and associated lethargy.